Webinar-Navigating the Private Equity Landscape: 2025 and Beyond

Share This Post
LinkedIn
Facebook
Threads

The private equity landscape in ophthalmology is shifting fast—and knowing where it’s headed matters. Join Matt Jensen for an insight-rich conversation with Chris Moore, CEO of Vision Innovation Partners, as they share firsthand insights into how PE groups are approaching deals today, what factors are driving valuations, and how the landscape is shaping up as we move toward 2026.

Join to the conversation: https://events.zoom.us/ev/AnEFuA4ItKEC8TZb-qAm-JlOMPZCJCIFmVa6RPFOX4hsadSnEEuM~Au5vA1AUBnvUTHw0CoPDtDUwz0wb5BQJ378FvBPD5NBrqmp-k4c5e2GOLA

Advanced IOLs & Interventional Glaucoma: Making Innovation Work | Dr. Paul Singh

Rethinking Ophthalmic Technician Training & Practice Growth | Practice Habits

Why 60% of Scheduled Glaucoma Surgeries Never Happen (And How to Fix It) | Ophtlamology Training

What Happens When AI Is Built Specifically for Ophthalmology?